After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
External Affairs Minister S Jaishankar held a meeting with US Secretary of State Antony Blinken o
JEE Main Exam 2025: This is a big change in the pattern of the JEE Main exam! know full details
The National Testing Agency (NTA) has made changes in the pattern of the question paper of JEE Ma
On Sunday, a big action was taken against Javed Mohammad, the mastermind of the ruckus in Atala i
Punjab CM Bhagwant Mann (48) has a second marriage on Thursday. He will take rounds with Dr. Gurp
Zaka Ashraf takes a U-turn on Dushman Mulk's comment: After the Pakistan team reached India, ther
The Election Commission has shown the prototype of the Remote Voting Machine ie RVM on Monday. A
After the defeat in the ODI series, Team India is going to play a two-Test series against Banglad
After Ranbir Kapoor's Animal, fans are eagerly waiting for his next film 'Ramayana'.&nb
Before the match between India and New Zealand on Sunday, Indian captain Virat Kohli held a virtu
After allegations of corruption in Delhi's new liquor policy, Deputy Chief Minister Manish Sisodi
